Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open Label Randomized Stratified Controlled Trial of the Effects of Blood Glucose Management on 90-Day All-Cause Mortality in a Heterogenous Population of Intensive Care Unit (ICU) Patients.

NCT00220987 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT00220987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00220987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open Label Randomized Stratified Controlled Trial of the Effects of Blood Glucose Management on 90-Day All-Cause Mortality in a Heterogenous Population of Intensive Care Unit (ICU) Patients.
Lead sponsor
The George Institute
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2005
Completion date
November 30, 2008
Enrollment
6,104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, hyperglycemia